1 | except | 7,548 |
2 | arguing | 91 |
3 | excepting | 43 |
4 | cairss | 5 |
5 | caryopteris | 3 |
6 | 0.8μg/ml | 2 |
7 | 12/1000 | 2 |
8 | 8.3±1.7 | 2 |
9 | chitomur | 2 |
10 | cu-histidine | 2 |
11 | five-days/week | 2 |
12 | hs-testing | 2 |
13 | lafmax | 2 |
14 | macce/readmission | 2 |
15 | newron | 2 |
16 | non-amenable | 2 |
17 | once/wk | 2 |
18 | position-controlled | 2 |
19 | sensitivity/1-specificity | 2 |
20 | whos | 2 |
21 | 'self-sacrificing | 1 |
22 | 'tools | 1 |
23 | +2.32 | 1 |
24 | -13.76 | 1 |
25 | -7.3±0.4 | 1 |
26 | .15-.71 | 1 |
27 | .41-.90 | 1 |
28 | 0.02-5μg/ml | 1 |
29 | 0.2254 | 1 |
30 | 0.45-3.66 | 1 |
31 | 0.49-1.80 | 1 |
32 | 0.61-0.61 | 1 |
33 | 0.62-1.57 | 1 |
34 | 0.72/0.62 | 1 |
35 | 0.73+/-0.01 | 1 |
36 | 0.76+/-0.01 | 1 |
37 | 0.77+/-0.01 | 1 |
38 | 0.77-2.95 | 1 |
39 | 0.81-1.28 | 1 |
40 | 0.83-0.92 | 1 |
41 | 0.88-1.46 | 1 |
42 | 0.97°c | 1 |
43 | 0.9±2.7 | 1 |
44 | 0·0244 | 1 |
45 | 0·118 | 1 |
46 | 0·232 | 1 |
47 | 0·668 | 1 |
48 | 0·736 | 1 |
49 | 0·768 | 1 |
50 | 0·98-7·38 | 1 |
51 | 1.0-100.0ng/ml | 1 |
52 | 1.04-3.41 | 1 |
53 | 1.08-2.04 | 1 |
54 | 1.09-1.73 | 1 |
55 | 1.13-1.50 | 1 |
56 | 1.20-3.86 | 1 |
57 | 1.24-4.48 | 1 |
58 | 1.26-1.84 | 1 |
59 | 1.26-4.93 | 1 |
60 | 1.29-1.37 | 1 |
61 | 1.37-7.31 | 1 |
62 | 1.38-23.47 | 1 |
63 | 1.3±4.1 | 1 |
64 | 1.43-5.11 | 1 |
65 | 1.5-150ng/ml | 1 |
66 | 1.71-1.98 | 1 |
67 | 1.8g | 1 |
68 | 10.00ng/ml | 1 |
69 | 100/91.3 | 1 |
70 | 102.00±24.49 | 1 |
71 | 103.00±24.98 | 1 |
72 | 12.41° | 1 |
73 | 13,088 | 1 |
74 | 13.00±3.80 | 1 |
75 | 131.0/77.0 | 1 |
76 | 14.36° | 1 |
77 | 15,883 | 1 |
78 | 16°/16° | 1 |
79 | 17.90±2.99 | 1 |
80 | 17°/24° | 1 |
81 | 18.55±2.89 | 1 |
82 | 18.85±3.12 | 1 |
83 | 18mmhg | 1 |
84 | 1:2913 | 1 |
85 | 1:43,701 | 1 |
86 | 1w.cm-2 | 1 |
87 | 2-mp | 1 |
88 | 2.057 | 1 |
89 | 2.17/0.94 | 1 |
90 | 2.25-3.66 | 1 |
91 | 2.3258 | 1 |
92 | 2.44/wk | 1 |
93 | 2.5mg/d | 1 |
94 | 2.88±0.09 | 1 |
95 | 2.8±1.3° | 1 |
96 | 2006-001858-27 | 1 |
97 | 233.3n | 1 |
98 | 24.20±2.78 | 1 |
99 | 269.0/117.0 | 1 |
100 | 283.0/267.9 | 1 |
101 | 296.3x | 1 |
102 | 2·73-4·97 | 1 |
103 | 2·77-5·22 | 1 |
104 | 3.06±0.09 | 1 |
105 | 3.13-5.10 | 1 |
106 | 3.72μmol/l | 1 |
107 | 3.9. | 1 |
108 | 30,665 | 1 |
109 | 301.2/258.2 | 1 |
110 | 301.2/286.2 | 1 |
111 | 305.45±23.95 | 1 |
112 | 315.3/300.2 | 1 |
113 | 340.40±13.06 | 1 |
114 | 341.90±14.04 | 1 |
115 | 343.85±14.88 | 1 |
116 | 36.7-4830.1 | 1 |
117 | 3·02-5·66 | 1 |
118 | 3·05-6·02 | 1 |
119 | 3·29-6·48 | 1 |
120 | 4.1-4.3 | 1 |
121 | 4.76ppm | 1 |
122 | 40.8mm | 1 |
123 | 407.2→371.3 | 1 |
124 | 413.2→331.2 | 1 |
125 | 44.9° | 1 |
126 | 47.9° | 1 |
127 | 49,977 | 1 |
128 | 5.1-20 | 1 |
129 | 5.3±0.6 | 1 |
130 | 5.5-10.2 | 1 |
131 | 5.68-fold | 1 |
132 | 5906.72 | 1 |
133 | 593.3/285.1 | 1 |
134 | 600bar | 1 |
135 | 67.720€ | 1 |
136 | 6x/day | 1 |
137 | 7,328 | 1 |
138 | 7032.14 | 1 |
139 | 73.4-2985.8 | 1 |
140 | 78.30±22.55 | 1 |
141 | 8,205 | 1 |
142 | 8.0±1.7 | 1 |
143 | 8.29±1.77 | 1 |
144 | 8.40±1.73 | 1 |
145 | 8.50° | 1 |
146 | 8.50±1.82 | 1 |
147 | 8127.9 | 1 |
148 | 85.0/67.0 | 1 |
149 | 87.0-11948.5 | 1 |
150 | 9.75° | 1 |
151 | 93.9-95.4 | 1 |
152 | 95.65±24.34 | 1 |
153 | 96.0/95.0 | 1 |
154 | 99.9° | 1 |
155 | a-419259 | 1 |
156 | account/control | 1 |
157 | analog-scale | 1 |
158 | battery-4 | 1 |
159 | campaigned | 1 |
160 | containment/support | 1 |
161 | d=-4.08 | 1 |
162 | d=0.745 | 1 |
163 | del5q | 1 |
164 | ephidrine | 1 |
165 | epically | 1 |
166 | euro1814 | 1 |
167 | euro953 | 1 |
168 | figuires | 1 |
169 | fomepizol | 1 |
170 | goalsetting | 1 |
171 | hoss | 1 |
172 | hr=1.21 | 1 |
173 | hr=3.8 | 1 |
174 | i.p./day | 1 |
175 | indications/dose | 1 |
176 | infants.data | 1 |
177 | japiccti-101075 | 1 |
178 | l*b* | 1 |
179 | ldl-hemoperfusion | 1 |
180 | legislative/advocacy | 1 |
181 | less-so | 1 |
182 | leu≤10 | 1 |
183 | leu≤11 | 1 |
184 | leu≤13 | 1 |
185 | militancy | 1 |
186 | n'-arylidene-2-oxo-2h-chromene-3-carbohydrazides | 1 |
187 | nct00457015 | 1 |
188 | next-to-highest | 1 |
189 | next-to-lowest | 1 |
190 | nntb/year | 1 |
191 | non-viraemic | 1 |
192 | nonsuitable | 1 |
193 | occlusiveness | 1 |
194 | p=.251 | 1 |
195 | p=.983 | 1 |
196 | p=0.00011 | 1 |
197 | p=0.451 | 1 |
198 | p=0.525 | 1 |
199 | p=0.849 | 1 |
200 | p=0.908 | 1 |
201 | pace-internet | 1 |
202 | pcmvi-ub | 1 |
203 | pd2+ | 1 |
204 | prerandomised | 1 |
205 | rea-son | 1 |
206 | rt+tamoxifen | 1 |
207 | specimen-collection | 1 |
208 | succussions | 1 |
209 | therapeutic-window | 1 |
210 | three-days/week | 1 |
211 | trimethoprim/sulfamethaxazole | 1 |
212 | trypanocidal.therapy | 1 |
213 | vaped/smoked | 1 |
214 | vegetable-like | 1 |
215 | vii-6-6/9 | 1 |
216 | western-hungary | 1 |
217 | xrcc1-399 | 1 |
218 | z-selectivity | 1 |
219 | £111.13 | 1 |
220 | £4 | 1 |
221 | ‘concern | 1 |
1 | 'self-sacrificing | 1 |
2 | 'tools | 1 |
3 | +2.32 | 1 |
4 | -13.76 | 1 |
5 | -7.3±0.4 | 1 |
6 | .15-.71 | 1 |
7 | .41-.90 | 1 |
8 | 0.02-5μg/ml | 1 |
9 | 0.2254 | 1 |
10 | 0.45-3.66 | 1 |
11 | 0.49-1.80 | 1 |
12 | 0.61-0.61 | 1 |
13 | 0.62-1.57 | 1 |
14 | 0.72/0.62 | 1 |
15 | 0.73+/-0.01 | 1 |
16 | 0.76+/-0.01 | 1 |
17 | 0.77+/-0.01 | 1 |
18 | 0.77-2.95 | 1 |
19 | 0.81-1.28 | 1 |
20 | 0.83-0.92 | 1 |
21 | 0.88-1.46 | 1 |
22 | 0.8μg/ml | 2 |
23 | 0.97°c | 1 |
24 | 0.9±2.7 | 1 |
25 | 0·0244 | 1 |
26 | 0·118 | 1 |
27 | 0·232 | 1 |
28 | 0·668 | 1 |
29 | 0·736 | 1 |
30 | 0·768 | 1 |
31 | 0·98-7·38 | 1 |
32 | 1.0-100.0ng/ml | 1 |
33 | 1.04-3.41 | 1 |
34 | 1.08-2.04 | 1 |
35 | 1.09-1.73 | 1 |
36 | 1.13-1.50 | 1 |
37 | 1.20-3.86 | 1 |
38 | 1.24-4.48 | 1 |
39 | 1.26-1.84 | 1 |
40 | 1.26-4.93 | 1 |
41 | 1.29-1.37 | 1 |
42 | 1.37-7.31 | 1 |
43 | 1.38-23.47 | 1 |
44 | 1.3±4.1 | 1 |
45 | 1.43-5.11 | 1 |
46 | 1.5-150ng/ml | 1 |
47 | 1.71-1.98 | 1 |
48 | 1.8g | 1 |
49 | 10.00ng/ml | 1 |
50 | 100/91.3 | 1 |
51 | 102.00±24.49 | 1 |
52 | 103.00±24.98 | 1 |
53 | 12.41° | 1 |
54 | 12/1000 | 2 |
55 | 13,088 | 1 |
56 | 13.00±3.80 | 1 |
57 | 131.0/77.0 | 1 |
58 | 14.36° | 1 |
59 | 15,883 | 1 |
60 | 16°/16° | 1 |
61 | 17.90±2.99 | 1 |
62 | 17°/24° | 1 |
63 | 18.55±2.89 | 1 |
64 | 18.85±3.12 | 1 |
65 | 18mmhg | 1 |
66 | 1:2913 | 1 |
67 | 1:43,701 | 1 |
68 | 1w.cm-2 | 1 |
69 | 2-mp | 1 |
70 | 2.057 | 1 |
71 | 2.17/0.94 | 1 |
72 | 2.25-3.66 | 1 |
73 | 2.3258 | 1 |
74 | 2.44/wk | 1 |
75 | 2.5mg/d | 1 |
76 | 2.88±0.09 | 1 |
77 | 2.8±1.3° | 1 |
78 | 2006-001858-27 | 1 |
79 | 233.3n | 1 |
80 | 24.20±2.78 | 1 |
81 | 269.0/117.0 | 1 |
82 | 283.0/267.9 | 1 |
83 | 296.3x | 1 |
84 | 2·73-4·97 | 1 |
85 | 2·77-5·22 | 1 |
86 | 3.06±0.09 | 1 |
87 | 3.13-5.10 | 1 |
88 | 3.72μmol/l | 1 |
89 | 3.9. | 1 |
90 | 30,665 | 1 |
91 | 301.2/258.2 | 1 |
92 | 301.2/286.2 | 1 |
93 | 305.45±23.95 | 1 |
94 | 315.3/300.2 | 1 |
95 | 340.40±13.06 | 1 |
96 | 341.90±14.04 | 1 |
97 | 343.85±14.88 | 1 |
98 | 36.7-4830.1 | 1 |
99 | 3·02-5·66 | 1 |
100 | 3·05-6·02 | 1 |
101 | 3·29-6·48 | 1 |
102 | 4.1-4.3 | 1 |
103 | 4.76ppm | 1 |
104 | 40.8mm | 1 |
105 | 407.2→371.3 | 1 |
106 | 413.2→331.2 | 1 |
107 | 44.9° | 1 |
108 | 47.9° | 1 |
109 | 49,977 | 1 |
110 | 5.1-20 | 1 |
111 | 5.3±0.6 | 1 |
112 | 5.5-10.2 | 1 |
113 | 5.68-fold | 1 |
114 | 5906.72 | 1 |
115 | 593.3/285.1 | 1 |
116 | 600bar | 1 |
117 | 67.720€ | 1 |
118 | 6x/day | 1 |
119 | 7,328 | 1 |
120 | 7032.14 | 1 |
121 | 73.4-2985.8 | 1 |
122 | 78.30±22.55 | 1 |
123 | 8,205 | 1 |
124 | 8.0±1.7 | 1 |
125 | 8.29±1.77 | 1 |
126 | 8.3±1.7 | 2 |
127 | 8.40±1.73 | 1 |
128 | 8.50° | 1 |
129 | 8.50±1.82 | 1 |
130 | 8127.9 | 1 |
131 | 85.0/67.0 | 1 |
132 | 87.0-11948.5 | 1 |
133 | 9.75° | 1 |
134 | 93.9-95.4 | 1 |
135 | 95.65±24.34 | 1 |
136 | 96.0/95.0 | 1 |
137 | 99.9° | 1 |
138 | a-419259 | 1 |
139 | account/control | 1 |
140 | analog-scale | 1 |
141 | arguing | 91 |
142 | battery-4 | 1 |
143 | cairss | 5 |
144 | campaigned | 1 |
145 | caryopteris | 3 |
146 | chitomur | 2 |
147 | containment/support | 1 |
148 | cu-histidine | 2 |
149 | d=-4.08 | 1 |
150 | d=0.745 | 1 |
151 | del5q | 1 |
152 | ephidrine | 1 |
153 | epically | 1 |
154 | euro1814 | 1 |
155 | euro953 | 1 |
156 | except | 7,548 |
157 | excepting | 43 |
158 | figuires | 1 |
159 | five-days/week | 2 |
160 | fomepizol | 1 |
161 | goalsetting | 1 |
162 | hoss | 1 |
163 | hr=1.21 | 1 |
164 | hr=3.8 | 1 |
165 | hs-testing | 2 |
166 | i.p./day | 1 |
167 | indications/dose | 1 |
168 | infants.data | 1 |
169 | japiccti-101075 | 1 |
170 | l*b* | 1 |
171 | lafmax | 2 |
172 | ldl-hemoperfusion | 1 |
173 | legislative/advocacy | 1 |
174 | less-so | 1 |
175 | leu≤10 | 1 |
176 | leu≤11 | 1 |
177 | leu≤13 | 1 |
178 | macce/readmission | 2 |
179 | militancy | 1 |
180 | n'-arylidene-2-oxo-2h-chromene-3-carbohydrazides | 1 |
181 | nct00457015 | 1 |
182 | newron | 2 |
183 | next-to-highest | 1 |
184 | next-to-lowest | 1 |
185 | nntb/year | 1 |
186 | non-amenable | 2 |
187 | non-viraemic | 1 |
188 | nonsuitable | 1 |
189 | occlusiveness | 1 |
190 | once/wk | 2 |
191 | p=.251 | 1 |
192 | p=.983 | 1 |
193 | p=0.00011 | 1 |
194 | p=0.451 | 1 |
195 | p=0.525 | 1 |
196 | p=0.849 | 1 |
197 | p=0.908 | 1 |
198 | pace-internet | 1 |
199 | pcmvi-ub | 1 |
200 | pd2+ | 1 |
201 | position-controlled | 2 |
202 | prerandomised | 1 |
203 | rea-son | 1 |
204 | rt+tamoxifen | 1 |
205 | sensitivity/1-specificity | 2 |
206 | specimen-collection | 1 |
207 | succussions | 1 |
208 | therapeutic-window | 1 |
209 | three-days/week | 1 |
210 | trimethoprim/sulfamethaxazole | 1 |
211 | trypanocidal.therapy | 1 |
212 | vaped/smoked | 1 |
213 | vegetable-like | 1 |
214 | vii-6-6/9 | 1 |
215 | western-hungary | 1 |
216 | whos | 2 |
217 | xrcc1-399 | 1 |
218 | z-selectivity | 1 |
219 | £111.13 | 1 |
220 | £4 | 1 |
221 | ‘concern | 1 |
1 | l*b* | 1 |
2 | pd2+ | 1 |
3 | 3.9. | 1 |
4 | 96.0/95.0 | 1 |
5 | 269.0/117.0 | 1 |
6 | 85.0/67.0 | 1 |
7 | 131.0/77.0 | 1 |
8 | 12/1000 | 2 |
9 | 3.13-5.10 | 1 |
10 | leu≤10 | 1 |
11 | 5.1-20 | 1 |
12 | 1.13-1.50 | 1 |
13 | 0.49-1.80 | 1 |
14 | 13.00±3.80 | 1 |
15 | .41-.90 | 1 |
16 | 36.7-4830.1 | 1 |
17 | 1.3±4.1 | 1 |
18 | 593.3/285.1 | 1 |
19 | 0.73+/-0.01 | 1 |
20 | 0.76+/-0.01 | 1 |
21 | 0.77+/-0.01 | 1 |
22 | 1:43,701 | 1 |
23 | 1.43-5.11 | 1 |
24 | p=0.00011 | 1 |
25 | leu≤11 | 1 |
26 | hr=1.21 | 1 |
27 | 1.37-7.31 | 1 |
28 | 1.04-3.41 | 1 |
29 | p=.251 | 1 |
30 | p=0.451 | 1 |
31 | 0.61-0.61 | 1 |
32 | .15-.71 | 1 |
33 | 1w.cm-2 | 1 |
34 | 315.3/300.2 | 1 |
35 | 5.5-10.2 | 1 |
36 | 413.2→331.2 | 1 |
37 | 301.2/286.2 | 1 |
38 | 301.2/258.2 | 1 |
39 | 3·05-6·02 | 1 |
40 | 18.85±3.12 | 1 |
41 | 2·77-5·22 | 1 |
42 | +2.32 | 1 |
43 | 0·232 | 1 |
44 | 0.72/0.62 | 1 |
45 | 5906.72 | 1 |
46 | 8.50±1.82 | 1 |
47 | 0.83-0.92 | 1 |
48 | 407.2→371.3 | 1 |
49 | 100/91.3 | 1 |
50 | 4.1-4.3 | 1 |
51 | £111.13 | 1 |
52 | 1:2913 | 1 |
53 | leu≤13 | 1 |
54 | euro953 | 1 |
55 | 1.09-1.73 | 1 |
56 | 8.40±1.73 | 1 |
57 | 15,883 | 1 |
58 | p=.983 | 1 |
59 | 1.26-4.93 | 1 |
60 | battery-4 | 1 |
61 | -7.3±0.4 | 1 |
62 | 93.9-95.4 | 1 |
63 | 1.08-2.04 | 1 |
64 | 341.90±14.04 | 1 |
65 | 7032.14 | 1 |
66 | euro1814 | 1 |
67 | 95.65±24.34 | 1 |
68 | 0·0244 | 1 |
69 | 0.2254 | 1 |
70 | 1.26-1.84 | 1 |
71 | 2.17/0.94 | 1 |
72 | £4 | 1 |
73 | 87.0-11948.5 | 1 |
74 | 8,205 | 1 |
75 | nct00457015 | 1 |
76 | p=0.525 | 1 |
77 | d=0.745 | 1 |
78 | 78.30±22.55 | 1 |
79 | 30,665 | 1 |
80 | japiccti-101075 | 1 |
81 | 0.77-2.95 | 1 |
82 | 305.45±23.95 | 1 |
83 | 5.3±0.6 | 1 |
84 | 340.40±13.06 | 1 |
85 | 0·736 | 1 |
86 | 0.88-1.46 | 1 |
87 | 2.25-3.66 | 1 |
88 | 0.45-3.66 | 1 |
89 | 3·02-5·66 | 1 |
90 | -13.76 | 1 |
91 | 1.20-3.86 | 1 |
92 | 8.0±1.7 | 1 |
93 | 8.3±1.7 | 2 |
94 | 0.9±2.7 | 1 |
95 | 2006-001858-27 | 1 |
96 | 1.29-1.37 | 1 |
97 | 1.38-23.47 | 1 |
98 | 0.62-1.57 | 1 |
99 | 2.057 | 1 |
100 | 8.29±1.77 | 1 |
101 | 49,977 | 1 |
102 | 2·73-4·97 | 1 |
103 | hr=3.8 | 1 |
104 | 73.4-2985.8 | 1 |
105 | d=-4.08 | 1 |
106 | p=0.908 | 1 |
107 | 0·118 | 1 |
108 | 0.81-1.28 | 1 |
109 | 7,328 | 1 |
110 | 0·98-7·38 | 1 |
111 | 1.24-4.48 | 1 |
112 | 3·29-6·48 | 1 |
113 | 2.3258 | 1 |
114 | 0·668 | 1 |
115 | 0·768 | 1 |
116 | 24.20±2.78 | 1 |
117 | 343.85±14.88 | 1 |
118 | 13,088 | 1 |
119 | 1.71-1.98 | 1 |
120 | 103.00±24.98 | 1 |
121 | 8127.9 | 1 |
122 | 283.0/267.9 | 1 |
123 | vii-6-6/9 | 1 |
124 | 3.06±0.09 | 1 |
125 | 2.88±0.09 | 1 |
126 | 102.00±24.49 | 1 |
127 | p=0.849 | 1 |
128 | a-419259 | 1 |
129 | 18.55±2.89 | 1 |
130 | 17.90±2.99 | 1 |
131 | xrcc1-399 | 1 |
132 | infants.data | 1 |
133 | pcmvi-ub | 1 |
134 | non-viraemic | 1 |
135 | 0.97°c | 1 |
136 | 2.5mg/d | 1 |
137 | vaped/smoked | 1 |
138 | position-controlled | 2 |
139 | campaigned | 1 |
140 | prerandomised | 1 |
141 | 5.68-fold | 1 |
142 | vegetable-like | 1 |
143 | analog-scale | 1 |
144 | non-amenable | 2 |
145 | nonsuitable | 1 |
146 | trimethoprim/sulfamethaxazole | 1 |
147 | cu-histidine | 2 |
148 | ephidrine | 1 |
149 | indications/dose | 1 |
150 | 1.8g | 1 |
151 | 18mmhg | 1 |
152 | 'self-sacrificing | 1 |
153 | excepting | 43 |
154 | hs-testing | 2 |
155 | goalsetting | 1 |
156 | arguing | 91 |
157 | three-days/week | 1 |
158 | five-days/week | 2 |
159 | 2.44/wk | 1 |
160 | once/wk | 2 |
161 | 3.72μmol/l | 1 |
162 | 1.0-100.0ng/ml | 1 |
163 | 10.00ng/ml | 1 |
164 | 1.5-150ng/ml | 1 |
165 | 0.02-5μg/ml | 1 |
166 | 0.8μg/ml | 2 |
167 | account/control | 1 |
168 | fomepizol | 1 |
169 | 40.8mm | 1 |
170 | 4.76ppm | 1 |
171 | 233.3n | 1 |
172 | rt+tamoxifen | 1 |
173 | macce/readmission | 2 |
174 | ldl-hemoperfusion | 1 |
175 | specimen-collection | 1 |
176 | newron | 2 |
177 | rea-son | 1 |
178 | ‘concern | 1 |
179 | less-so | 1 |
180 | 2-mp | 1 |
181 | del5q | 1 |
182 | 600bar | 1 |
183 | nntb/year | 1 |
184 | chitomur | 2 |
185 | n'-arylidene-2-oxo-2h-chromene-3-carbohydrazides | 1 |
186 | figuires | 1 |
187 | caryopteris | 3 |
188 | 'tools | 1 |
189 | succussions | 1 |
190 | whos | 2 |
191 | occlusiveness | 1 |
192 | hoss | 1 |
193 | cairss | 5 |
194 | pace-internet | 1 |
195 | except | 7,548 |
196 | containment/support | 1 |
197 | next-to-highest | 1 |
198 | next-to-lowest | 1 |
199 | therapeutic-window | 1 |
200 | 296.3x | 1 |
201 | lafmax | 2 |
202 | i.p./day | 1 |
203 | 6x/day | 1 |
204 | legislative/advocacy | 1 |
205 | militancy | 1 |
206 | epically | 1 |
207 | trypanocidal.therapy | 1 |
208 | western-hungary | 1 |
209 | sensitivity/1-specificity | 2 |
210 | z-selectivity | 1 |
211 | 67.720€ | 1 |
212 | 8.50° | 1 |
213 | 12.41° | 1 |
214 | 2.8±1.3° | 1 |
215 | 17°/24° | 1 |
216 | 9.75° | 1 |
217 | 16°/16° | 1 |
218 | 14.36° | 1 |
219 | 44.9° | 1 |
220 | 47.9° | 1 |
221 | 99.9° | 1 |